Antic et al evaluated the impact of comorbidities on the NCCN-IPI in pateints with diffuse large B-cell lymphoma. The authors are from Clinical Center of Serbia, University of Belgrade, Clinical Center Nis and Clinical Hospital Center "Bezanijska Kosa".
Patient selection: diffuse large B-cell lymphoma
Parameters:
(1) NCCN-IPI (from 0 to 8)
(2) Charlson comorbidity index (CCI)
Parameter
Finding
Points
Charlson comorbidity
0 or 1
0
>= 2 (high)
3
comorbidity NCCN-IPI =
= (NCCN-IPI) + (points for the Charlson comorbidity score)
Interpretation:
• minimum score: 0
• maximum score: 11
Score
Risk Group
5-Year Overall Survival
0
low
100%
1 or 2
low-intermediate
79%
3 to 5
high-intermediate
50%
>= 6
high
14%
To read more or access our algorithms and calculators, please log in or register.
